# Biomarin Pharmaceuticals Inc – FDA Inspection, Dec 6, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceuticals-inc/fcfc761b-3ba9-472d-9254-2f50523d5062
Source feed: FDA_Inspections

> FDA inspection 1000920 of Biomarin Pharmaceuticals Inc, December 06, 2016. 2 citations under 21 CFR part 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000920
- Company Name: Biomarin Pharmaceuticals Inc
- Inspection Date: 2016-12-06
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 2

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [FDA Associated Person](https://www.keypedia.com/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)
- [FDA Associated Person](https://www.keypedia.com/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)

Company: https://www.keypedia.com/companies/biomarin-pharmaceuticals-inc/bd1063c9-0493-4e38-a9d5-d9a69d5f1531

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df